Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome. Issue 214 (June 2022)

• Record Type: Journal Article
• Authors: Mazetto, Bruna de Moraes; Hounkpe, Bidossessi Wilfried; da Silva Saraiva, Sabrina; Vieira-Damiani, Gislaine; dos Santos, Ana Paula Rosa; Jacinto, Bruna Cardoso; Vaz, Camila de Oliveira; Mesquita, Gabriela Tripiquia Vechiatto; Annichino-Bizzacchi, Joyce Maria; De Paula, Erich Vinicius; Orsi, Fernanda Andrade
• Is Part Of: Thrombosis research. Issue 214(2022)
• Page Start: 132
• Page End: 137
• Publication Date: 2022-06
• Subjects: Antiphospholipid -- Thrombosis -- NETosis markers -- Neutrophil extracellular traps -- mRNA; Thrombosis -- Periodicals; 616.135
• DOI: 10.1016/j.thromres.2022.05.001
• Languages: English
• ISSNs: 0049-3848

Abstract

Abstract: Background: The release of neutrophil extracellular traps (NETs) is the basis of immune-mediated thrombosis. Data on the clinical relevance of NETs in antiphospholipid syndrome-related thrombosis are scarce. Objective: The aim of this study was to evaluate whether the NET regulator proteins PADI4, ELANE, and MPO are associated with thrombosis in APS. Methods: A total of 152 thrombotic APS (t-APS) patients and 123 individuals without thrombosis (controls) were included. The following markers of NETs were evaluated: PADI4, ELANE, and MPO gene expression by qPCR and circulating levels of citrullinated histone H3 (H3cit) and myeloperoxidase–DNA complexes (MPO-DNA) by ELISA. Results: The levels of circulating MPO-DNA and MPO mRNA expression and PADI4 mRNA expression were higher in t-APS patients than in controls. The mean differences were 0.05 OD (95% CI 0.01 to 0.09) in MPO-DNA levels, 1.07 AU (95% CI 0.20 to 1.93) for MPO mRNA and 0.20 AU (95% CI 0.03 to 0.36) in PADI4 mRNA fold-change. These differences were more pronounced in triple-positive patients, who had 56% increased levels of MPO-DNA, 44% increased MPO mRNA expression and 69% increased PADI4 mRNA expression compared to controls. Additionally, circulating MPO-DNA levels and MPO mRNA expression were higher in patients with recurrent thrombosis than in patients with incident thrombosis and controls. In recurrent thrombosis, levels of MPO-DNA were 43.8% higher and MPO mRNA expression was 2-fold higher than in controls. Levels of circulating MPO-DNA and PADI4 mRNA expression did not differ substantially between primary and secondary APS. Conclusion: Thrombotic APS was associated with increased NET formation, which was more pronounced among patients with poorer prognosis, such as those with triple antiphospholipid positivity and recurrent thrombosis. Our results provide evidence on the association of NETs and the severity of APS-related thrombosis.